DP
TMO icon

Dearborn Partners’s Thermo Fisher Scientific TMO Stock Holding History

Dearborn Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-483
Closed -$299K – 274
2024
Q3 		$299K Buy
483
+4
+0.8% +$2.37K 0.01% 224
2024
Q2 		$265K Buy
479
+115
+32% +$65.9K 0.01% 230
2024
Q1 		$212K Sell
364
-66
-15% -$37K 0.01% 256
2023
Q4 		$228K Buy
430
+29
+7% +$14K 0.01% 240
2023
Q3 		$203K Sell
401
-12
-3% -$6.39K 0.01% 232
2023
Q2 		$215K Buy
413
+7
+2% +$3.78K 0.01% 225
2023
Q1 		$234K Sell
406
-456
-53% -$257K 0.01% 219
2022
Q4 		$475K Buy
862
+330
+62% +$175K 0.02% 161
2022
Q3 		$270K Buy
532
+10
+2% +$5.6K 0.01% 202
2022
Q2 		$284K Hold
522
– – 0.01% 203
2022
Q1 		$308K Buy
522
+83
+19% +$47.7K 0.01% 204
2021
Q4 		$293K Hold
439
– – 0.01% 220
2021
Q3 		$251K Hold
439
– – 0.01% 217
2021
Q2 		$221K Buy
+439
New +$207K 0.01% 237
2015
Q3 		– Sell
-2,471
Closed -$321K – 217
2015
Q2 		$321K Sell
2,471
-3,056
-55% -$398K 0.03% 183
2015
Q1 		$743K Sell
5,527
-42
-0.8% -$5.41K 0.07% 188
2014
Q4 		$698K Buy
5,569
+275
+5% +$33.4K 0.06% 191
2014
Q3 		$644K Buy
+5,294
New +$644K 0.06% 192

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dearborn Partners's TMO Position: Q4 2024 in Review

Dearborn Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 483 shares — an estimated $299K sold.

Dearborn Partners first reported a position in TMO in Q3 2014 and held it in 18 quarters. The position peaked at $743K in Q1 2015. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Dearborn Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Dearborn Partners sold 483 Thermo Fisher Scientific shares in Q4 2024, an estimated $299K.
  • Dearborn Partners first reported a position in Thermo Fisher Scientific in Q3 2014 and held it in 18 quarters.
  • Dearborn Partners's Thermo Fisher Scientific position peaked at $743K in Q1 2015.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Dearborn Partners's 13F filing for Q4 2024, filed 7 Feb 2025.